Invited commentary  by Clouse, W. Darrin
JOURNAL OF VASCULAR SURGERY
874 Clouse October 2014however, because of our concerns about the relatively unpredict-
able nature of the chimney-to-aortic endograft and native aorta
interaction, we would recommend imaging at 1 month, 3 months,
and every 6 months thereafter for the ﬁrst 24 months, then prob-
ably tailor the intervals on the basis of impressions of stent architec-
ture and aneurysm sac involution.
The bigger issue, though, is the second part of your ﬁrst ques-
tion regarding how to manage a gutter leak resulting in a persistent
type Ia endoleak with sac enlargement. Some authors recommend
that you extend the repair proximally and get more overlap; how-
ever, this can be more challenging than it sounds and may require
additional chimney lengthening or visceral stenting. Notably, we
had a relatively low incidence of type Ia endoleak in our series
compared with what is reported in the literature, which is probably
related to the 25-mm average seal that was achieved with the repair
that may have consequently led to elevated rates of chimney stent
failure due to the increased overlap. With that being said, the
impact of this complication cannot be overstated as one patient un-
derwent conversion. We have a second patient who is likely to ul-
timately undergo conversion, so barring the ability to extend more
proximally, which often involves putting more chimney stents into
the renal or mesenteric vessels, I do not think that there is a
straightforward solution.
To your second question about the drop in glomerular ﬁltra-
tion rate, again, to my previous point, there were not always clues
on postoperative imaging that the patients were developing stent
deformation. However, even in vessels thought to have optimal
anatomy for chimney placement, we have seen deformation
without clinical consequences such as a change in glomerular ﬁltra-
tion rate, stent thrombosis, or abdominal pain. I would like to
bring your attention to one example. Many authors embrace the
notion that a down-going vessel is more advantageous for a chim-
ney stent procedure. The superior mesenteric artery is classically a
down-going vessel; however, these slides are an example of a su-
prarenal aortic aneurysm that was repaired with chimney EVAR
in our practice. Initial chimney placement resulted in some stent
compression without clinical symptoms or duplex velocities sug-
gestive of stenosis. However, over time, CT scans demonstrated
greater compression and eventual thrombosis, which surprisingly
and fortunately was asymptomatic for this patient. Some authors
might argue, “well, you should place additional self-expanding
stents to support the stent graft,” which highlights one of the chal-
lenges with interpreting the chimney literature. Speciﬁcally, there isno standardized technique. We used combinations of virtually all
known aortic endografts and stent/stent grafts because of the
complexity of the disease patterns we treated, and no single device
combination seemed to be more frequently associated with fail-
ures. I think it is very difﬁcult to reliably predict the biomechanical
properties of the interface between the different aortic endografts
and the various permutations of chimney stents or stent grafts
that are reported. For example, two of the patients in this series
who experienced bilateral renal chimney stent thrombosis had
stent grafts (one patient had Fluencys and a Zenith graft, one pa-
tient had Viabahns and a Gore graft) with internally supported self-
expanding Zilver stents, and they still ended up with thrombosis.
Chimney stent failure is not simply explained by architecture
and stent deformation. In an effort to try to understand the differ-
ences in hemodynamic perturbations that occur in stented visceral
vessels after chimney and fenestrated EVAR, one of my colleagues,
Scott Berceli, has some preliminary data that demonstrate that
there is tremendous variation in shear stress that occurs in the
visceral vessels after chimney stent placement. These studies may
provide mechanistic insights as to why it is that some of these
stents go on to fail even without architectural abnormalities on
CT or alterations in duplex velocities.
With respect to your third question about why it is that an in-
ternal iliac chimney with a type Ib leak may have a more benign
course compared with a type Ia leak, I am unaware of any compel-
ling clinical data that could argue for relative “safety” of one leak
compared with the other. Conceptually, from a purely ﬂow dynamic
and pressure principle argument, it should not make a difference
where the type I endoleak originates. However, I am aware that
there are some suggestions in the literature that support the notion
that type Ib internal iliac chimney leaks may be more benign. One
possible explanation is that there are different biomechanical proper-
ties of the iliac limbs compared with the hoop strength that you
encounter with an aortic endograft, leading to better conformability
between the iliac stents. Also the length of overlap is often different.
It is possible that the longer internal iliac chimney stent gutter has a
smaller cross-sectional diameter leading to relatively greater ﬂow
resistance and pressure drop compared with a shorter proximal
aortic gutter with larger diameters. Also, depending on how the in-
ternal iliac chimney is constructed, the “type Ib leak” may really be
behaving like a type II leak, depending on the conﬁguration of the
proximal aortic stent and distal external iliac seal zone, especially if
you have constructed an “internal” chimney.INVITED COMMENTARYW. Darrin Clouse, MD, Sacramento, CalifAs I read “Critical analysis of results after chimney EVAR raises
cause for concern,” by Scali and colleagues, I very much appreciated
the candor in experience and temperance in thought from the excel-
lent University of Florida group. This report describes the operative
andmonitored outcomes in 41 patients with 76 renovisceral “chim-
ney” grafts with endovascular aortic repair (chEVAR) up to a me-
dian of 18 months. Intraoperative complications occurred in 17%
and major postoperative complications in 20%, with an in-hospital
mortality of 7%; 32% of patients developed endoleak after discharge,
even with respectable “chimney neck” attained. Freedom from rein-
tervention was 96% at 3 years, with target vessel patency of 85% at 3
years. Although survival at 5 years was 65%, estimated freedom from
major adverse events (MAEs) was only 57%; 49% of this cohort
developed some type of complication! Many MAEs occurred later
than 1 year. Obvious criticisms of this small, descriptive report un-
derscore varied selection biases for differing treatments, the many
aortic disease extents included, and main body oversizing methods
as well as employment of myriad endograft/branch graft conﬁgura-
tions in the cohort. They conclude that chEVAR should be reserved
for those clearly not open candidates and those in whom fenestrated
EVAR (fEVAR) is not possible.Look, on face value, these data are really not decidedly different
from the current operative and early-term CHIMPS literature
showing surprising early success. Kastargyris1 and Donas2 have
both performed literature-pooled analysis suggesting similar aortic
and systemic outcomes for chEVAR and fEVAR, except for slightly
higher chEVAR stroke rates with transarch access from the arms.
Banno et al3 have just now communicated as much in their large
single-center report of chEVAR compared with fEVAR out to 1
year. What is different here is the suggestion of signiﬁcant later
failure.
In terms of branch and aneurysm outcomes, Scali’s somber
note is not currently corroborated in 24-month data from Europe,
where endoleak and branch occlusion rates are declared to be in
the single-digit percentage range with reasonable sac regression.4
However, issues surrounding renal function and systemic adversity
were missing. Lee and the accomplished Stanford group are also
not seeing signiﬁcant branch thrombosis, but a similar effect on
later renal function is intimated at 23 months, which they accept.5
Is the combined end point including only a $25% reduction in
estimated glomerular ﬁltration rate during the long term a fair
MAE inclusion?
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Vascular Surgery, remain skeptical of CHIMPS approaches. The
gutter morphology and mechanical effects are not reassuring,
and miserable failures due to proximal leak are described. Little
is known about the hemodynamic effects, physiology, and char-
acter of forces when multiple metal and fabric tubes are parallel
in a singular compliant tissue tube, not to mention how chimney
versus periscope placements might alter these factors. Scali
describes their difﬁculty in surveillance of the renovisceral branches
and how imaging seemed unpredictable in portending in-stent ste-
nosis and failure, which was the chief MAE, not a small problem.
It is no secret that selection criteria among centers and
groups for chEVAR are far from uniform, with many chEVAR
patients either urgent in nature or not anatomic candidates for
fEVAR. In fact, these 41 patients represent only 5% of the Uni-
versity of Florida aortic endograft experience. The gorilla in the
corner, then, remains longer term durability in chEVAR and how
to compare experiences! This report suggests that durability may
not be good, and others in this treatment arena clamor for a well-
developed “real-world” registry to provide more meaningful
insight and meticulous comparison. We should expect no less.
And, are we really surprised? Was not this approach truly devel-
oped as a bailout technique and a makeshift therapy anticipating
other technologies for those we know are poor open repair can-
didates? The anticipation is gone; fEVAR is here. The reality is
simply that now, those undergoing chEVAR are probably not
fEVAR candidates because of urgency or anatomy. Are theysimply at higher failure risk regardless? Using technology in
ways it was not intended can be precarious. We skeptically
embraced chEVAR. We were then surprised with initial
outcomes. Now, as Scali and colleagues suggest, we may ulti-
mately realize the stopgap was real.REFERENCES
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